Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis.
cystic fibrosis
drug delivery
gene therapy
lung pathology
nanoparticles
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
10
2019
accepted:
27
11
2019
entrez:
11
1
2020
pubmed:
11
1
2020
medline:
11
1
2020
Statut:
epublish
Résumé
Cystic fibrosis (CF) is a genetic disease affecting today nearly 70,000 patients worldwide and characterized by a hypersecretion of thick mucus difficult to clear arising from the defective CFTR protein. The over-production of the mucus secreted in the lungs, along with its altered composition and consistency, results in airway obstruction that makes the lungs susceptible to recurrent and persistent bacterial infections and endobronchial chronic inflammation, which are considered the primary cause of bronchiectasis, respiratory failure, and consequent death of patients. Despite the difficulty of treating the continuous infections caused by pathogens in CF patients, various strategies focused on the symptomatic therapy have been developed during the last few decades, showing significant positive impact on prognosis. Moreover, nowadays, the discovery of CFTR modulators as well as the development of gene therapy have provided new opportunity to treat CF. However, the lack of effective methods for delivery and especially targeted delivery of therapeutics specifically to lung tissues and cells limits the efficiency of the treatments. Nanomedicine represents an extraordinary opportunity for the improvement of current therapies and for the development of innovative treatment options for CF previously considered hard or impossible to treat. Due to the peculiar environment in which the therapies have to operate characterized by several biological barriers (pulmonary tract, mucus, epithelia, bacterial biofilm) the use of nanotechnologies to improve and enhance drug delivery or gene therapies is an extremely promising way to be pursued. The aim of this review is to revise the currently used treatments and to outline the most recent progresses about the use of nanotechnology for the management of CF.
Identifiants
pubmed: 31921811
doi: 10.3389/fbioe.2019.00406
pmc: PMC6927921
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
406Informations de copyright
Copyright © 2019 Velino, Carella, Adamiano, Sanguinetti, Vitali, Catalucci, Bugli and Iafisco.
Références
Chest. 2004 Feb;125(2):509-21
pubmed: 14769732
Adv Mater. 2011 Mar 18;23(11):1376-9
pubmed: 21400599
J Cyst Fibros. 2009 Sep;8(5):295-315
pubmed: 19559658
Minerva Pediatr. 2019 Aug;71(4):371-375
pubmed: 30761821
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12001-5
pubmed: 12200546
Drugs. 2003;63(22):2501-20
pubmed: 14609360
BMJ. 2007 Dec 15;335(7632):1255-9
pubmed: 18079549
Orphanet J Rare Dis. 2014 Nov 30;9:189
pubmed: 25433388
Antimicrob Agents Chemother. 1994 May;38(5):1090-5
pubmed: 8067743
N Engl J Med. 2015 Jul 16;373(3):220-31
pubmed: 25981758
Int J Pharm. 2010 Jun 30;393(1-2):167-75
pubmed: 20362042
Mol Pharm. 2014 Jun 2;11(6):1808-22
pubmed: 24811243
Int J Pharm. 2006 Jun 6;315(1-2):59-66
pubmed: 16551496
Eur J Pharm Biopharm. 2018 Jul;128:1-9
pubmed: 29605468
Cochrane Database Syst Rev. 2016 Feb 11;2:CD003428
pubmed: 26866910
J Pharm Sci. 2012 Sep;101(9):3347-59
pubmed: 22623044
Science. 2004 Apr 23;304(5670):600-2
pubmed: 15105504
J Pharm Pharmacol. 2012 Sep;64(9):1217-35
pubmed: 22881435
Tanaffos. 2012;11(4):18-22
pubmed: 25191433
Eur J Pharm Biopharm. 2017 Aug;117:363-371
pubmed: 28476373
Pediatr Pulmonol. 2013 Nov;48(11):1047-61
pubmed: 24000183
Adv Drug Deliv Rev. 2009 Feb 27;61(2):128-39
pubmed: 19138713
Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:19-28
pubmed: 30573241
Eur J Pharm Biopharm. 2014 Jan;86(1):7-22
pubmed: 24007657
Int J Pharm. 2004 Jan 28;269(2):457-67
pubmed: 14706257
Drug Discov Today. 2010 Mar;15(5-6):171-85
pubmed: 20116448
Pharmacotherapy. 2010 Dec;30(12):1279-91
pubmed: 21114395
Paediatr Drugs. 2010 Dec 1;12(6):343-52
pubmed: 21028914
Mol Pharm. 2010 Feb 1;7(1):86-93
pubmed: 19886674
J Control Release. 2012 Jan 10;157(1):149-59
pubmed: 21864595
Antimicrob Agents Chemother. 2009 Sep;53(9):3847-54
pubmed: 19451281
Cell Death Differ. 2017 Nov;24(11):1825-1844
pubmed: 28937684
Mol Pharm. 2016 Jun 6;13(6):1866-78
pubmed: 27148629
Respir Care. 2009 May;54(5):595-605
pubmed: 19393104
Methods Find Exp Clin Pharmacol. 2001 Dec;23(10):531-6
pubmed: 11957743
J Antimicrob Chemother. 2008 Apr;61(4):859-68
pubmed: 18305202
Front Biosci (Elite Ed). 2010 Jan 01;2:424-40
pubmed: 20036890
Nanomedicine. 2015 Jul;11(5):1189-99
pubmed: 25659645
Pulm Pharmacol Ther. 2008 Aug;21(4):595-9
pubmed: 18234534
Hum Pathol. 1982 Oct;13(10):934-9
pubmed: 7129409
J Control Release. 2014 Mar 28;178:8-17
pubmed: 24440664
AAPS J. 2005 Mar 24;7(1):E20-41
pubmed: 16146340
J Aerosol Med Pulm Drug Deliv. 2011 Aug;24(4):175-82
pubmed: 21395432
Sci Rep. 2017 Apr 6;7(1):700
pubmed: 28386087
Gene Ther. 2003 Aug;10(16):1282-8
pubmed: 12883524
J Cyst Fibros. 2019 Jan;18(1):22-34
pubmed: 29934203
J Gene Med. 2011 Apr;13(4):200-8
pubmed: 21322102
Nanomedicine (Lond). 2016 Apr;11(8):891-906
pubmed: 26979495
Expert Opin Drug Deliv. 2011 Apr;8(4):451-66
pubmed: 21375469
Clin Ther. 2013 Oct;35(10):1571-81
pubmed: 24054830
Nat Commun. 2018 Jun 26;9(1):2481
pubmed: 29946143
Eur J Pharm Biopharm. 2018 Jul;128:27-35
pubmed: 29654885
Prog Med Chem. 2018;57(1):235-276
pubmed: 29680149
J Microencapsul. 1997 May-Jun;14(3):335-48
pubmed: 9147283
Ther Clin Risk Manag. 2018 Dec 06;14:2375-2383
pubmed: 30584312
Med Devices (Auckl). 2011;4:179-88
pubmed: 22915944
Pulm Pharmacol Ther. 2018 Jun;50:82-87
pubmed: 29660401
Nat Nanotechnol. 2019 Mar;14(3):287-297
pubmed: 30692673
Expert Rev Respir Med. 2019 Aug;13(8):709-725
pubmed: 31215818
Sci Transl Med. 2018 Jan 17;10(424):
pubmed: 29343624
Eur J Pharm Biopharm. 2000 Jul;50(1):161-77
pubmed: 10840199
Biomaterials. 2009 May;30(13):2591-7
pubmed: 19176245
Biochim Biophys Acta. 2000 Feb 15;1463(2):254-66
pubmed: 10675504
Chest. 2003 Jul;124(1):360-6
pubmed: 12853545
Int J Antimicrob Agents. 2006 Mar;27(3):247-52
pubmed: 16472992
Paediatr Respir Rev. 2018 Jan;25:64-72
pubmed: 28372929
Eur Respir J. 1999 Jul;14(1):221-9
pubmed: 10489856
Eur Respir J. 2014 Sep;44(3):765-74
pubmed: 24791828
J Transl Med. 2017 Apr 27;15(1):84
pubmed: 28449677
Int J Pharm. 2010 Mar 15;387(1-2):187-98
pubmed: 19969054
Int J Mol Sci. 2017 May 16;18(5):null
pubmed: 28509852
J Nanobiotechnology. 2010 Sep 24;8:22
pubmed: 20868490
J Cyst Fibros. 2019 Nov;18(6):829-837
pubmed: 30857926
Thorax. 2018 Sep;73(9):847-856
pubmed: 29748250
Pharmazie. 2001 Oct;56(10):783-6
pubmed: 11683123
J Cyst Fibros. 2005 Aug;4 Suppl 2:45-8
pubmed: 16005266
ACS Appl Mater Interfaces. 2018 Jan 10;10(1):165-181
pubmed: 29235345
Hum Gene Ther. 2007 Aug;18(8):726-32
pubmed: 17685853
Biomaterials. 2015 Mar;45:10-7
pubmed: 25662490
Adv Ther. 2015 Jan;32(1):1-9
pubmed: 25620537
Expert Opin Drug Deliv. 2009 Jan;6(1):71-89
pubmed: 19236209
Int J Pharm. 2009 Jan 21;366(1-2):170-84
pubmed: 18992314
PLoS One. 2017 Sep 13;12(9):e0184793
pubmed: 28902888
Paediatr Respir Rev. 2007 Mar;8(1):24-9
pubmed: 17419975
Ann Pharmacother. 2012 Jul-Aug;46(7-8):1065-75
pubmed: 22739718
Eur J Pharm Biopharm. 2008 Feb;68(2):413-21
pubmed: 17574400
Nat Biotechnol. 2018 Mar;36(3):265-271
pubmed: 29431739
Thorax. 2013 Apr;68(4):344-50
pubmed: 23135343
Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S131-55
pubmed: 12460720
Front Pharmacol. 2019 Feb 27;10:121
pubmed: 30873022
Int J Pharm. 2008 May 1;355(1-2):293-8
pubmed: 18164881
Adv Mater. 2012 Jul 24;24(28):3887-94
pubmed: 22988559
Expert Opin Drug Deliv. 2019 Feb;16(2):177-186
pubmed: 30732491
J Control Release. 2011 Oct 30;155(2):289-95
pubmed: 21843562
Int J Mol Sci. 2014 Apr 08;15(4):5852-73
pubmed: 24717409
Drugs. 2014 Mar;74(3):377-87
pubmed: 24510624
PLoS One. 2009 May 28;4(5):e5724
pubmed: 19479000
Curr Med Chem. 2010;17(6):585-94
pubmed: 20015030
Eur Respir Rev. 2018 Apr 13;27(148):null
pubmed: 29653946
Trends Biotechnol. 2007 Dec;25(12):563-70
pubmed: 17997181
Nat Genet. 1993 Oct;5(2):135-42
pubmed: 7504552
N Engl J Med. 2011 Nov 3;365(18):1663-72
pubmed: 22047557
Int J Pharm. 2006 Jul 6;317(1):82-9
pubmed: 16580159
J Cyst Fibros. 2012 Sep;11(5):419-26
pubmed: 22717535
Biochem Pharmacol. 2002 Nov 1;64(9):1407-13
pubmed: 12392822
N Engl J Med. 1996 Jul 18;335(3):179-88
pubmed: 8657217
Drug Dev Ind Pharm. 2017 Jul;43(7):1071-1081
pubmed: 28270008
Microb Pathog. 2018 Dec;125:122-128
pubmed: 30217514
J Control Release. 2014 Jun 10;183:18-26
pubmed: 24637466
Mol Ther. 2018 Aug 1;26(8):2034-2046
pubmed: 29910178
Front Pharmacol. 2019 Feb 01;10:20
pubmed: 30774592
Am J Respir Cell Mol Biol. 2013 Aug;49(2):288-95
pubmed: 23590300
Colloids Surf B Biointerfaces. 2016 Mar 1;139:219-27
pubmed: 26720142
Biomed Res Int. 2013;2013:136859
pubmed: 23984315
Biochim Biophys Acta. 2014 Jan;1840(1):586-94
pubmed: 24141140
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):151-5
pubmed: 25779350
J Intern Med. 2015 Feb;277(2):155-166
pubmed: 25266997
Front Pharmacol. 2016 Sep 05;7:275
pubmed: 27656143
ERJ Open Res. 2019 Jun 17;5(2):null
pubmed: 31218221
Lung. 2012 Jun;190(3):251-62
pubmed: 22274758
Colloids Surf B Biointerfaces. 2008 Feb 15;61(2):138-44
pubmed: 17890065
Int J Pharm. 2007 Mar 21;333(1-2):187-98
pubmed: 17084567
J Antimicrob Chemother. 2015 Nov;70(11):2945-55
pubmed: 26203182
PLoS One. 2013 Nov 14;8(11):e79220
pubmed: 24244452
J Cyst Fibros. 2012 Dec;11(6):461-79
pubmed: 23137712
Int J Pharm. 2018 Jun 10;544(1):75-82
pubmed: 29608955
J Cyst Fibros. 2014 Dec;13(6):674-80
pubmed: 25266159
Eur J Pharm Biopharm. 2018 Oct;131:120-129
pubmed: 30063969
Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1231-52
pubmed: 23619573
Annu Rev Biochem. 1977;46:723-63
pubmed: 197881
J Cyst Fibros. 2003 Mar;2(1):19-24
pubmed: 15463841
N Engl J Med. 2005 May 12;352(19):1992-2001
pubmed: 15888700
J Antimicrob Chemother. 2003 May;51 Suppl 1:1-11
pubmed: 12702698
Lancet. 2009 May 30;373(9678):1891-904
pubmed: 19403164
Eur J Pharm Biopharm. 2009 Feb;71(2):161-72
pubmed: 18824097
Gene Ther. 1997 Mar;4(3):210-8
pubmed: 9135734
Cell Death Differ. 2016 Aug;23(8):1380-93
pubmed: 27035618
Curr Opin Immunol. 2015 Feb;32:36-41
pubmed: 25574773
PLoS One. 2016 Jun 03;11(6):e0156690
pubmed: 27257956
Int J Pharm. 2018 Dec 20;553(1-2):57-64
pubmed: 30268850
J Pharmacol Exp Ther. 2001 Jul;298(1):369-75
pubmed: 11408564
Int J Biochem Cell Biol. 2014 Jul;52:94-102
pubmed: 24631642
J Antimicrob Chemother. 2007 Oct;60(4):760-9
pubmed: 17673475
Nat Commun. 2015 Apr 27;6:6952
pubmed: 25914116
J Biomed Mater Res B Appl Biomater. 2008 Jul;86(1):105-12
pubmed: 18098198
Patient Prefer Adherence. 2017 Apr 27;11:831-838
pubmed: 28490864
Chest. 2010 Nov;138(5):1202-12
pubmed: 21051396
Core Evid. 2011;6:59-66
pubmed: 22022288
Antimicrob Agents Chemother. 1996 Mar;40(3):665-9
pubmed: 8851590
Lancet Respir Med. 2015 Sep;3(9):684-691
pubmed: 26149841
Biochim Biophys Acta. 1999 Aug 5;1428(2-3):334-40
pubmed: 10434052
J Cyst Fibros. 2014 May;13 Suppl 1:S23-42
pubmed: 24856775
Pharm Res. 2006 May;23(5):931-40
pubmed: 16715383
Eur J Pharm Sci. 2005 Jul-Aug;25(4-5):427-37
pubmed: 15893461
Med Princ Pract. 2016;25 Suppl 2:60-72
pubmed: 26938856
Chest. 2003 Jan;123(1):28-36
pubmed: 12527599
Ther Deliv. 2015 Feb;6(2):121-37
pubmed: 25690082
BMC Med. 2011 Apr 04;9:32
pubmed: 21463524
Biophys Rev. 2017 Oct;9(5):793-803
pubmed: 28914424
Lancet Respir Med. 2016 Aug;4(8):662-674
pubmed: 27053340
Autophagy. 2014;10(11):2053-74
pubmed: 25350163
BMC Pulm Med. 2016 Dec 5;16(1):174
pubmed: 27919253
Respir Med. 2011 Dec;105 Suppl 2:S2-8
pubmed: 22208546
Am J Respir Crit Care Med. 2012 Jan 15;185(2):171-8
pubmed: 22095545
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96
pubmed: 11311991
Sci Rep. 2018 Nov 13;8(1):16776
pubmed: 30425265
J Control Release. 2010 Mar 19;142(3):299-311
pubmed: 19874861
Pharm Res. 1998 Nov;15(11):1775-81
pubmed: 9834002
Adv Drug Deliv Rev. 2002 Dec 5;54(11):1409-23
pubmed: 12458152
Eur Respir J. 1994 Mar;7(3):442-5
pubmed: 8013599
Int J Pharm. 2017 Jul 15;527(1-2):171-183
pubmed: 28549971
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Eur J Pharm Biopharm. 2011 May;78(1):90-6
pubmed: 21145394
J Pers Med. 2018 Nov 24;8(4):null
pubmed: 30477208
J Antimicrob Chemother. 2005 Feb;55(2):269-71
pubmed: 15590716
SLAS Technol. 2019 Apr;24(2):169-180
pubmed: 30707858
J Drug Target. 2013 Dec;21(10):914-25
pubmed: 23978292
Clin Drug Investig. 2013 Jun;33(6):419-27
pubmed: 23605507
Adv Drug Deliv Rev. 2014 Aug;75:92-111
pubmed: 24842473
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
N Engl J Med. 2004 Aug 5;351(6):606-8
pubmed: 15295056
Am J Respir Crit Care Med. 2011 Jun 1;183(11):1510-6
pubmed: 21471106
Cell. 1993 Oct 22;75(2):207-16
pubmed: 7691415
J Control Release. 2015 Dec 10;219:500-518
pubmed: 26297206
J Liposome Res. 2010 Jun;20(2):97-104
pubmed: 19621981
Int J Pharm. 2008 May 22;356(1-2):239-47
pubmed: 18358652
Eur J Pharm Biopharm. 2017 Nov;120:9-21
pubmed: 28780275
J Antimicrob Chemother. 2008 Dec;62(6):1291-7
pubmed: 18931388
Respir Care. 2009 May;54(5):658-70
pubmed: 19393109
Breathe (Sheff). 2015 Jun;11(2):110-8
pubmed: 26306111
Int J Nanomedicine. 2013;8:3907-15
pubmed: 24143095
Cell. 2014 Jun 5;157(6):1262-78
pubmed: 24906146
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1092-1103
pubmed: 27104944
Paediatr Respir Rev. 2017 Mar;22:47-49
pubmed: 27964951
Antimicrob Agents Chemother. 2006 Jun;50(6):2016-22
pubmed: 16723560
Cell Stem Cell. 2013 Dec 5;13(6):653-8
pubmed: 24315439
Expert Opin Biol Ther. 2017 Oct;17(10):1265-1273
pubmed: 28657358
Pulm Pharmacol Ther. 2013 Dec;26(6):700-9
pubmed: 23933140
Nanomedicine (Lond). 2011 Feb;6(2):365-75
pubmed: 21385138
Science. 2018 Oct 5;362(6410):86-91
pubmed: 30166439
Curr Pharm Des. 2012;18(5):642-62
pubmed: 22229571
Int J Nanomedicine. 2010 Dec 16;6:35-43
pubmed: 21289980
Nat Commun. 2019 Aug 7;10(1):3556
pubmed: 31391465
J Clin Gastroenterol. 2005 Apr;39(4):307-17
pubmed: 15758625
Hum Mol Genet. 2013 Oct 15;22(R1):R52-8
pubmed: 23918661
Front Microbiol. 2018 Jul 05;9:1349
pubmed: 30026732